Tracy Swan

3.5k total citations · 2 hit papers
31 papers, 1.5k citations indexed

About

Tracy Swan is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Tracy Swan has authored 31 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Hepatology, 23 papers in Epidemiology and 12 papers in Infectious Diseases. Recurrent topics in Tracy Swan's work include Hepatitis C virus research (26 papers), Hepatitis B Virus Studies (19 papers) and Liver Disease Diagnosis and Treatment (10 papers). Tracy Swan is often cited by papers focused on Hepatitis C virus research (26 papers), Hepatitis B Virus Studies (19 papers) and Liver Disease Diagnosis and Treatment (10 papers). Tracy Swan collaborates with scholars based in United States, United Kingdom and Australia. Tracy Swan's co-authors include Lynn E. Taylor, Gregory J. Dore, Jason Grebely, Brian R. Edlin, Scott D. Holmberg, Benjamin Eckhardt, Marla A. Shu, Robert A. Greenwald, Kenneth H. Mayer and Camilla S. Graham and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and Gastroenterology.

In The Last Decade

Tracy Swan

29 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Toward a more accurate estimate of the prevalence of hepatitis C in the United States

2015 330 citations Tracy Swan et al. profile →
Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United States

2015 326 citations Jason Grebely, Gregory J. Dore et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tracy Swan United States	16	1.2k	1.2k	341	93	66	31	1.5k
Sarah Blach Switzerland	15	2.1k 1.7×	2.0k 1.7×	338 1.0×	41 0.4×	23 0.3×	43	2.3k
Oluwaseun Falade‐Nwulia United States	20	1.0k 0.8×	1.1k 0.9×	393 1.2×	66 0.7×	24 0.4×	75	1.6k
Amanda Yu Canada	22	912 0.7×	1.0k 0.9×	177 0.5×	45 0.5×	16 0.2×	67	1.3k
Carolyn Wester United States	11	715 0.6×	667 0.6×	159 0.5×	58 0.6×	29 0.4×	25	869
Benjamin Eckhardt United States	14	522 0.4×	586 0.5×	194 0.6×	60 0.6×	15 0.2×	32	779
Tuyen Hoang United States	14	428 0.3×	646 0.5×	313 0.9×	184 2.0×	250 3.8×	22	1.1k
Stacey Trooskin United States	16	490 0.4×	527 0.4×	217 0.6×	120 1.3×	29 0.4×	30	725
Stanley Wong Canada	18	600 0.5×	679 0.6×	172 0.5×	32 0.3×	18 0.3×	59	924
Anthony Yartel United States	9	1.4k 1.2×	1.4k 1.2×	128 0.4×	50 0.5×	19 0.3×	19	1.6k
Philip Bruggmann Switzerland	18	1.0k 0.8×	1.0k 0.9×	237 0.7×	59 0.6×	15 0.2×	73	1.2k

Countries citing papers authored by Tracy Swan

Since Specialization

Citations

This map shows the geographic impact of Tracy Swan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tracy Swan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tracy Swan more than expected).

Fields of papers citing papers by Tracy Swan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tracy Swan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tracy Swan. The network helps show where Tracy Swan may publish in the future.

Co-authorship network of co-authors of Tracy Swan

This figure shows the co-authorship network connecting the top 25 collaborators of Tracy Swan. A scholar is included among the top collaborators of Tracy Swan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tracy Swan. Tracy Swan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rockstroh, Jürgen K., et al.. (2023). The path to hepatitis C elimination: who are we leaving behind and why?. Journal of the International AIDS Society. 26(7). e26136–e26136. 10 indexed citations

Bremen, Kathrin van, et al.. (2023). Hepatitis delta in HIV/hepatitis B coinfection: A call for action. HIV Medicine. 25(3). 319–321. 1 indexed citations

Picchio, Camila A, Jorge Valencia, Tracy Swan, et al.. (2020). The impact of the COVID-19 pandemic on harm reduction services in Spain. Harm Reduction Journal. 17(1). 87–87. 40 indexed citations

Pedrana, Alisa, Jessica Howell, Nick Scott, et al.. (2020). Global hepatitis C elimination: an investment framework. The Lancet. Gastroenterology & hepatology. 5(10). 927–939. 31 indexed citations

Lamoury, F., Behzad Hajarizadeh, Evan B. Cunningham, et al.. (2017). Hepatitis C virus core antigen: A simplified treatment monitoring tool, including for post-treatment relapse. Journal of Clinical Virology. 92. 32–38. 24 indexed citations

Maponga, Tongai, Sébastien Morin, Andrew Scheibe, et al.. (2017). Highlights from the 3rd international HIV/viral hepatitis Co-infection meeting - HIV/viral hepatitis: improving diagnosis, antiviral therapy and access. SHILAP Revista de lepidopterología. 2(1). 8–8. 7 indexed citations

Wolfe, Daniel, et al.. (2015). Human rights and access to hepatitis C treatment for people who inject drugs. International Journal of Drug Policy. 26(11). 1072–1080. 43 indexed citations

Grebely, Jason, Geert Robaeys, Philip Bruggmann, et al.. (2015). Recommendations for the management of hepatitis C virus infection among people who inject drugs. International Journal of Drug Policy. 26(10). 1028–1038. 135 indexed citations

Harris, Magdalena, et al.. (2015). The promise of treatment as prevention for hepatitis C: Meeting the needs of people who inject drugs?. International Journal of Drug Policy. 26(10). 963–969. 22 indexed citations

10.

Ford, Nathan, Stefan Z. Wiktor, Karyn Kaplan, et al.. (2015). Ten priorities for expanding access to HCV treatment for people who inject drugs in low- and middle-income countries. International Journal of Drug Policy. 26(11). 1088–1093. 24 indexed citations

11.

Grebely, Jason, Geert Robaeys, Philip Bruggmann, et al.. (2015). Recomendaciones para el manejo de la infección por el virus de la hepatitis C entre usuarios de drogas por vía parenteral. International Journal of Drug Policy. 111. 101671–101671.

12.

Graham, Camilla S. & Tracy Swan. (2015). A path to eradication of hepatitis C in low- and middle-income countries. Antiviral Research. 119. 89–96. 79 indexed citations

13.

Ford, Nathan, Tracy Swan, Peter Beyer, et al.. (2014). Simplification of antiviral hepatitis C virus therapy to support expanded access in resource-limited settings. Journal of Hepatology. 61(1). S132–S138. 21 indexed citations

14.

Kwong, Ann D., et al.. (2014). Accelerating Drug Development Through Collaboration: The Hepatitis C Drug Development Advisory Group. Clinical Pharmacology & Therapeutics. 96(2). 162–165. 9 indexed citations

15.

Robaeys, Geert, Jason Grebely, Stefan Mauss, et al.. (2013). Recommendations for the Management of Hepatitis C Virus Infection Among People Who Inject Drugs. Clinical Infectious Diseases. 57(suppl 2). S129–S137. 86 indexed citations

16.

Aronsohn, Andrew, Andrew J. Muir, Tracy Swan, & Donald M. Jensen. (2013). Is the HCV Pipeline Heading in the Right Direction?. Gastroenterology. 144(3). 482–485. 4 indexed citations

17.

Taylor, Lynn E., Tracy Swan, & Gail Matthews. (2013). Management of Hepatitis C Virus/HIV Coinfection Among People Who Use Drugs in the Era of Direct-Acting Antiviral–Based Therapy. Clinical Infectious Diseases. 57(suppl_2). S118–S124. 40 indexed citations

18.

Taylor, Lynn E., Tracy Swan, & Kenneth H. Mayer. (2012). HIV Coinfection With Hepatitis C Virus: Evolving Epidemiology and Treatment Paradigms. Clinical Infectious Diseases. 55(suppl 1). S33–S42. 119 indexed citations

19.

Raboud, Janet, Aranka Anema, DeSheng Su, et al.. (2012). Relationship of Chronic Hepatitis C Infection to Rates of AIDS-Defining Illnesses in a Canadian Cohort of HIV Seropositive Individuals Receiving Highly Active Antiretroviral Therapy. HIV Clinical Trials. 13(2). 90–102. 5 indexed citations

20.

Weiss, Jeffrey J., et al.. (2009). Review article: adherence to medication for chronic hepatitis C – building on the model of human immunodeficiency virus antiretroviral adherence research. Alimentary Pharmacology & Therapeutics. 30(1). 14–27. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact